Early diagnosis of sepsis using serum biomarkers

References

• Wang P, Yang Z, He Y, Shu C. Pitfalls in the rapid diagnosis of positive blood culture. Rev. Med. Microbiol.21(3), 39–43 (2010).
   Google Scholar
• Kauss IAM, Grion CMC, Cardoso LTQ et al. The epidemiology of sepsis in a Brazilian teaching hospital. Brazilian J. Infect. Dis.14(3), 264–270 (2010).
   PubMedGoogle Scholar
• Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med.29(7), 1303–1310 (2001).
   PubMed Web of Science ®Google Scholar
• Cetinkaya M, Ozkan H, Koksal N, Celebi S, Hacimustafaoglu M. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. J. Perinatol.29(3), 225–231 (2009).
   PubMed Web of Science ®Google Scholar
• Zecca E, Barone G, Corsello M et al. Reliability of two different bedside assays for C-reactive protein in newborn infants. Clin. Chem. Lab. Med.47(9), 1081–1084 (2009).
   PubMed Web of Science ®Google Scholar
• Ipek IO, Saracoglu M, Bozaykut A. α(1)-acid glycoprotein for the early diagnosis of neonatal sepsis. J. Matern. Fetal Neonatal Med.23(7), 617–621 (2010).
   PubMed Web of Science ®Google Scholar
• Rego MAC, Martinez FE, Elias J, Mussi-Pinhata MM. Diagnostic value of interleukin-6 and C-reactive protein on early onset bacterial infection in preterm neonates with respiratory distress. J. Perinat. Med.38(5), 527–533 (2010).
   PubMed Web of Science ®Google Scholar
• Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am. J. Respir. Crit. Care Med.167(5), 695–701 (2003).
   PubMed Web of Science ®Google Scholar
• Cardelli P, Ferraironi M, Amode R et al. Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis. Int. J. Immunopathol. Pharmacol.21(1), 43–49 (2008).
   PubMed Web of Science ®Google Scholar
• Cheng BL, Xie GH, Yao SL et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit. Care Med.35, 2538–2546 (2007).
   PubMed Web of Science ®Google Scholar
• Sankar MJ, Agarwal R, Deorari AK, Paul VK. Sepsis in the newborn. Indian J. Pediatr.75(3), 261–266 (2008).
   PubMed Web of Science ®Google Scholar
• Hunter P. Sepsis under siege – a new understanding of sepsis might lead to the development of therapies to treat septic shock. EMBO Rep.7, 667–669 (2006).
   PubMedGoogle Scholar
• Desmet SS. The problem of sepsis – an expert report of the European-Society-Of-Intensive-Care-Medicine. Intensive Care Med.20(4), 300–304 (1994).
   PubMedGoogle Scholar
• Arnon S, Litmanovitz I. Diagnostic tests in neonatal sepsis. Curr. Opin. Infect. Dis.21(3), 223–227 (2008).
   PubMedGoogle Scholar
• Zeitoun AAH, Gad SS, Attia FM, Abu Maziad AS, Bell EF. Evaluation of neutrophilic CD64, interleukin 10 and procalcitonin as diagnostic markers of early- and late-onset neonatal sepsis. Scand. J. Infect. Dis.42(4), 299–305 (2010).
   PubMed Web of Science ®Google Scholar
• Nijhuis CSMO, Vellenga E, Daenen SMGJ et al. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients. Intensive Care Med.29(12), 2157–2161 (2003).
   PubMedGoogle Scholar
• Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit. Care Med.36(3), 941–952 (2008).
   PubMed Web of Science ®Google Scholar
• Oh JS, Kim SU, Oh YM et al. The usefulness of the semiquantitative procalcitonin test kit as a guideline for starting antibiotic administration. Am. J. Emerg. Med.27(7), 859–863 (2009).
   PubMedGoogle Scholar
• Maubon D, Hamidfar-Roy R, Courby S et al. Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. J. Infect.61(4), 335–342 (2010).
   PubMed Web of Science ®Google Scholar
• Lannergard A, Larsson A, Friman G, Ewald U. Human serum amyloid A (SAA) and high sensitive C-reactive protein (hsCRP) in preterm newborn infants with nosocomial infections. Acta Paediat.97(8), 1061–1065 (2008).
   PubMed Web of Science ®Google Scholar
• Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, Vincent JL. Procalcitonin levels in surgical patients at risk of candidemia. J. Infect.60(6), 425–430 (2010).
   PubMed Web of Science ®Google Scholar
• Sakr Y, Sponhoz C, Tuche F, Brunkhorst F, Reinhart K. The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection36(5), 396–407 (2008).
   PubMed Web of Science ®Google Scholar
• von Lilienfeld-Toal M, Lehmann LE, Raadts AD et al. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J. Clin. Microbiol.47(8), 2405–2410 (2009).
   PubMed Web of Science ®Google Scholar
• Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit. Care14(1), R15 (2010).
   PubMed Web of Science ®Google Scholar
• Schultz MJ, Determann RM. PCT and sTREM-1: the markers of infection in critically ill patients? Med. Sci. Monit.14(12), RA241–RA247 (2008).
   PubMedGoogle Scholar
• Kennon C, Overturf G, Bessman S, Sierra E, Smith KJ, Brann B. Granulocyte colony-stimulating factor as a marker for bacterial infection in neonates. J. Pediatr.128(6), 765–769 (1996).
   PubMed Web of Science ®Google Scholar
• Groselj-Grenc M, Ihan A, Pavcnik-Arnol M, Kopitar AN, Gmeiner-Stopar T, Derganc M. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med.35(11), 1950–1958 (2009).
   PubMed Web of Science ®Google Scholar
• Arnon S, Litmanovitz I, Regev RH, Bauer S, Shainkin-Kestenbaum R, Dolfin T. Serum amyloid A: an early and accurate marker of neonatal early-onset sepsis. J. Perinatol.27(5), 297–302 (2007).
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Bergmann OJ, Larsson L, Nielsen HV, Jarlov JO, Christensson B. Detection of candidaemia in patients with and without underlying haematological disease. Clin. Microbiol. Infect.16(7), 855–862 (2010).
   PubMed Web of Science ®Google Scholar
• Bille J. New nonculture-based methods for the diagnosis of invasive candidiasis. Curr. Opin. Crit. Care.16(5), 460–464 (2010).
   PubMed Web of Science ®Google Scholar
• Doherty M, Wallis RS, Zumla A, WHO Tropical Dis. Res. Biomarkers for tuberculosis disease status and diagnosis. Curr. Opin. Pulm. Med.15(3), 181–187 (2009).
   PubMed Web of Science ®Google Scholar
• Marshall JC, Reinhart K, Int. Sepsis Forum. Biomarkers of sepsis. Crit. Care Med.37(7), 2290–2298 (2009).
   PubMed Web of Science ®Google Scholar
• Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit. Care Med.27(3), 498–504 (1999).
   PubMed Web of Science ®Google Scholar
• Kim KE, Han JY. Evaluation of the clinical performance of an automated procalcitonin assay for the quantitative detection of bloodstream infection. Korean J. Lab. Med.30(2), 153–159 (2010).
   PubMedGoogle Scholar
• Chiriboga DE, Ma YS, Li WJ et al. Seasonal and sex variation of high-sensitivity C-reactive protein in healthy adults: a longitudinal study. Clin. Chem.55(2), 313–321 (2009).
   PubMed Web of Science ®Google Scholar
• Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin. Infect. Dis.39(2), 206–217 (2004).
   PubMed Web of Science ®Google Scholar
• Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics112(5), 1054–1060 (2003).
   PubMed Web of Science ®Google Scholar
• Lacour AG, Gervaix A, Zamora SA et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur. J. Pediatr.160(2), 95–100 (2001).
   PubMed Web of Science ®Google Scholar
• Agapakis DI, Tsantilas D, Psarris P et al. Coagulation and inflammation biomarkers may help predict the severity of community-acquired pneumonia. Respirology15(5), 796–803 (2010).
   PubMed Web of Science ®Google Scholar
• Enguix A, Rey C, Concha A, Medina A, Coto D, Dieguez MA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med.27(1), 211–215 (2001).
   PubMed Web of Science ®Google Scholar
• Edgar JDM, Gabriel V, Gallimore JR, McMillan SA, Grant J. A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection. BMC Pediatr.10, 22 (2010).
   PubMed Web of Science ®Google Scholar
• Lannergard A, Friman G, Ewald U, Lind L, Larsson A. Serum amyloid A (SAA) protein and high-sensitivity C-reactive protein (hsCRP) in healthy newborn infants and healthy young through elderly adults. Acta Paediatr.94(9), 1198–1202 (2005).
   PubMed Web of Science ®Google Scholar
• Fioretto JR, Martin JG, Kurokawa CS et al. Comparison between procalcitonin and C-reactive protein for early diagnosis of children with sepsis or septic shock. Inflamm. Res.59(8), 581–586 (2010).
   PubMed Web of Science ®Google Scholar
• dos Anjos BL, Grotto HZW. Evaluation of C-reactive protein and serum amyloid A in the detection of inflammatory and infectious diseases in children. Clin. Chem. Lab. Med.48(4), 493–499 (2010).
   PubMedGoogle Scholar
• Petrikkos GL, Christofilopoulou SA, Tentolouris NK, Charvalos EA, Kosmidis CJ, Daikos GL. Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections. Eur. J. Clin. Microbiol. Infect. Dis.24(4), 272–275 (2005).
   PubMed Web of Science ®Google Scholar
• Gibot S, Kolopp-Sarda MN, Bene MC et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann. Intern. Med.141(1), 9–15 (2004).
   PubMed Web of Science ®Google Scholar
• Kajiya T, Orihara K, Hamasaki S et al. Toll-like receptor 2 expression level on monocytes in patients with viral infections: monitoring infection severity. J. Infect.57(3), 249–259 (2008).
   PubMed Web of Science ®Google Scholar
• Lannergard A, Viberg A, Cars O, Karlsson MO, Sandstrom M, Larsson A. The time course of body temperature, serum amyloid A protein, C-reactive protein and interleukin-6 in patients with bacterial infection during the initial 3 days of antibiotic therapy. Scand. J. Infect. Dis.41(9), 663–671 (2009).
   PubMed Web of Science ®Google Scholar
• Claessens YE, Schmidt J, Batard E et al. Can C-reactive protein, procalcitonin and mid-regional pro-atrial natriuretic peptide measurements guide choice of in-patient or out-patient care in acute pyelonephritis? Biomarkers In Sepsis (BIS) multicentre study. Clin. Microbiol. Infect.16(6), 753–760 (2010).
   PubMed Web of Science ®Google Scholar
• Claessens YE, Mathevon T, Kierzek G et al. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia. Intensive Care Med.36(5), 799–809 (2010).
   PubMed Web of Science ®Google Scholar
• Whicher JT, Chambers RE, Higginson J, Nashef L, Higgins PG. Acute phase response of serum amyloid-A protein and C-reactive protein to the common cold and influenza. J. Clin. Pathol.38(3), 312–316 (1985).
   PubMed Web of Science ®Google Scholar
• Quint JK, Donaldson GC, Goldring JJP, Baghai-Ravary R, Hurst JR, Wedzicha JA. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD. Chest137(4), 812–822 (2010).
   PubMed Web of Science ®Google Scholar
• Nakamura A, Wada H, Ikejiri M et al. Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit. Shock31(6), 586–591 (2009).
   PubMed Web of Science ®Google Scholar
• Deis JN, Creech CB, Estrada CM, Abramo TJ. Procalcitonin as a marker of severe bacterial infection in children in the emergency department. Pediatr. Emerg. Care26(1), 51–63 (2010).
   PubMedGoogle Scholar
• Dong HM, Shu W, Liu TC et al. Targeting procalcitonin with novel murine monoclonal antibodies. Hybridoma29(3), 189–194 (2010).
   PubMedGoogle Scholar
• Schuetz P, Christ-Crain M, Huber AR, Muller B. Long-term stability of procalcitonin in frozen samples and comparison of Kryptor and VIDAS automated immunoassays. Clin. Biochem.43(3), 341–344 (2010).
   PubMed Web of Science ®Google Scholar
• Manzano S, Bailey B, Girodias JB, Cousineau J, Delvin E, Gervaix A. Comparison of procalcitonin measurement by a semi-quantitative method and an ultra-sensitive quantitative method in a pediatric emergency department. Clin. Biochem.42(15), 1557–1560 (2009).
   PubMedGoogle Scholar
• Limper M, de Kruif MD, Duits AJ, Brandjes DPM, van Gorp ECM. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J. Infect.60(6), 409–416 (2010).
   PubMed Web of Science ®Google Scholar
• Oshita H, Sakurai J, Kamitsuna M. Semi-quantitative procalcitonin test for the diagnosis of bacterial infection: clinical use and experience in Japan. J. Microbiol. Immunol. Infect.43(3), 222–227 (2010).
   PubMedGoogle Scholar
• Wunderink RG. Surrogate markers and microbiologic end points. Clin. Infect. Dis.51, S126–S130 (2010).
   PubMedGoogle Scholar
• Dubos F, Moulin F, Gajdos V et al. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J. Pediatr.149(1), 72–76 (2006).
   PubMedGoogle Scholar
• Pavic M, Bronic A, Kopcinovic LM. Procalcitonin in systemic and localized bacterial infection. Biochemia Medica20(2), 236–241 (2010).
   Google Scholar
• Gilbert DN. Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J. Clin. Microbiol.48(7), 2325–2329 (2010).
   PubMed Web of Science ®Google Scholar
• Schneider CP, Yilmaz Y, Kleespies A, Jauch KW, Hartl WH. Accuracy of procalcitonin for outcome prediction in unselected postoperative critically ill patients. Shock31(6), 568–573 (2009).
   PubMed Web of Science ®Google Scholar
• Lopez AF, Cubells CL, Garcia JJG, Pou JF. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr. Infect. Dis. J.22(10), 895–903 (2003).
   PubMedGoogle Scholar
• Kelly D, Khan SQ, Dhillon O et al. Procalcitonin as a prognostic marker in patients with acute myocardial infarction. Biomarkers15(4), 325–331 (2010).
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Opal SM. Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Criti. Care14(1), 203 (2010).
   PubMed Web of Science ®Google Scholar
• Mira JP, Max A, Burgel PR. The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy. Critical Care12(Suppl. 6), S5 (2008).
   PubMedGoogle Scholar
• Cetinkaya M, Ozkan H, Koksal N, Akaci O, Ozgur T. The efficacy of serial serum amyloid A measurements for diagnosis and follow-up of necrotizing enterocolitis in premature infants. Pediatr. Surg. Int.26(8), 835–841 (2010).
   PubMed Web of Science ®Google Scholar
• Ellis M, Al-Ramadi B, Bernsen R, Kristensen J, Alizadeh H, Hedstrom U. Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J. Med. Microbiol.58(5), 606–615 (2009).
   PubMed Web of Science ®Google Scholar
• Sendid B, Jouault T, Coudriau R et al. Increased sensitivity of mannanemia detection tests by joint detection of α- and β-linked oligomannosides during experimental and human systemic candidiasis. J. Clin. Microbiol.42(1), 164–171 (2004).
   PubMed Web of Science ®Google Scholar
• Ng PC, Li K, Chui KM et al. IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr. Res.61(1), 93–98 (2007).
   PubMed Web of Science ®Google Scholar
• Sumino KC, Walter MJ, Mikols CL et al. Detection of respiratory viruses and the associated chemokine responses in serious acute respiratory illness. Thorax65(7), 639–644 (2010).
   PubMedGoogle Scholar
• Wang JA, Wang PP, Xiang GJ, Hu XB. Relationship between the expression of IP-10 and IP-10 mRNA in peripheral blood and HBV DNA level in patients with cirrhosis. Hepatobiliary Pancreat. Dis. Int.9(3), 280–286 (2010).
   PubMedGoogle Scholar
• Lagging M, Romero AI, Westin J et al. IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology44(6), 1617–1625 (2006).
   PubMed Web of Science ®Google Scholar
• Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children. Intensive Care Med.33(6), 1025–1032 (2007).
   PubMed Web of Science ®Google Scholar
• Nuutila J, Hohenthal U, Laitinen L et al. Simultaneous quantitative analysis of FcγRI (CD64) expression on neutrophils and monocytes: a new, improved way to detect infections. J. Immunol. Methods328(1–2), 189–200 (2007).
   PubMed Web of Science ®Google Scholar
• Nuutila J. The novel applications of the quantitative analysis of neutrophil cell surface Fc γ RI (CD64) to the diagnosis of infectious and inflammatory diseases. Curr. Opin. Infect. Dis.23(3), 268–274 (2010).
   PubMed Web of Science ®Google Scholar
• Cid J, Aguinaco R, Sanchez R, Garcia-Pardo G, Llorente A. Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis. J. Infect.60(5), 313–319 (2010).
   PubMed Web of Science ®Google Scholar
• Hoffmann JJML. Neutrophil CD64: a diagnostic marker for infection and sepsis. Clin. Chem. Lab. Med.47(8), 903–916 (2009).
   PubMed Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin. Chem. Lab. Med.41(1), 68–73 (2003).
   PubMed Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin. Chem.49(1), 7–18 (2003).
   PubMed Web of Science ®Google Scholar
• Schunemann HJ, Oxman AD, Brozek J et al. GRADE: assessing the quality of evidence for diagnostic recommendations. Evid. Based Med.13(6), 162–3 (2008).
   PubMedGoogle Scholar
• Schunemann HJ, Schunemann AHJ, Oxman AD et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ336(7653), 1106–1110 (2008).
   PubMed Web of Science ®Google Scholar
• Yager P, Domingo GJ, Gerdes J. Point-of-care diagnostics for global health. Annu. Rev. Biomed. Eng.10, 107–144 (2008).
   PubMed Web of Science ®Google Scholar
• Peeling RW, Mabey D. Point-of-care tests for diagnosing infections in the developing world. Clin. Microbiol. Infect.16(8), 1062–1069 (2010).
   PubMed Web of Science ®Google Scholar
• Aguilera-Herrador E, Cruz-Vera M, Valcarcel M. Analytical connotations of point-of-care testing. Analyst135(9), 2220–2232 (2010).
   PubMed Web of Science ®Google Scholar
• Rusling JF, Kumar CV, Gutkind JS, Patel V. Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. Analyst135(10), 2496–2511 (2010).
   PubMed Web of Science ®Google Scholar
• Mtapuri-Zinyowera S, Chideme M, Mangwanya D et al. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J. Acquir. Immune Defic. Syndr.55(1), 1–7 (2010).
   PubMed Web of Science ®Google Scholar
• Wilkins J, Gallimore JR, Moore EG, Pepys MB. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin. Chem.44(6), 1358–1361 (1998).
   PubMed Web of Science ®Google Scholar
• Chourrout P. Procalcitonin: from discovery to clinical use. Medecine Nucleaire–Imagerie Fonctionnelle et Metabolique32(3), 132–137 (2008).
   Google Scholar
• Wilkins J, Gallimore JR, Tennent GA et al. Rapid automated enzyme-immunoassay of serum amyloid-A. Clin. Chem.40(7), 1284–1290 (1994).
   PubMedGoogle Scholar